Literature DB >> 4758051

Long-term treatment of persistent or recurrent urinary tract infection with trimethoprim-sulfamethoxazole.

F O'Grady, I K Fry, A McSherry, W R Cattell.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1973        PMID： 4758051     DOI： 10.1093/infdis/128.supplement_3.s652

Source DB:  PubMed          Journal:  J Infect Dis        ISSN： 0022-1899            Impact factor:   5.226


× No keyword cloud information.
  6 in total

1.  Prophylaxis of recurring urinary tract infection in females: a comparison of nitrofurantoin with trimethoprim-sulfamethoxazole.

Authors:  A R Ronald; C K Harding; R Mathias; C K Wong; P Muir
Journal:  Can Med Assoc J       Date:  1975-06-14       Impact factor: 8.262

2.  Comparison of sulfamethoxazole alone and combined with trimethoprim in urinary tract infections.

Authors:  T Bergan; O Skjerven
Journal:  Infection       Date:  1979       Impact factor: 3.553

3.  General survey of trimethoprim combinations in the treatment of urinary tract infections.

Authors:  W Brumfitt; J M Hamilton-Miller
Journal:  Infection       Date:  1979       Impact factor: 3.553

4.  Nitrofurantoin versus trimethoprim for low-dose long-term prophylaxis in patients with recurrent urinary tract infections. A prospective randomized study.

Authors:  W Vahlensieck; M Westenfelder
Journal:  Int Urol Nephrol       Date:  1992       Impact factor: 2.370

5.  Normal somatic growth in children receiving low-dose prophylactic co-trimoxazole.

Authors:  J M Smellie; M A Preece; A M Paton
Journal:  Eur J Pediatr       Date:  1983-09       Impact factor: 3.183

6.  Effect of trimethoprim and trimethoprim-sulfamethoxazole on development of drug-resistant vaginal and fecal floras.

Authors:  S J Pancoast; D M Hyams; H C Neu
Journal:  Antimicrob Agents Chemother       Date:  1980-02       Impact factor: 5.191
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.